UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2017
Commission File Number 000-26495
Cyren Ltd.
(Translation of Registrant’s name into English)
1 Sapir Road, 5th Floor, Beit Ampa, P.O. Box 4014, Herzliya 46140, Israel
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):___
On November 13, 2017, the Registrant issued a press release announcing its Q3 2017 financial results. A copy of the press release is annexed hereto as Exhibit 1 and incorporated herein by reference.
The US GAAP information set forth in the Condensed Consolidated Statements of Operations, Condensed Consolidated Balance Sheets and Condensed Consolidated Cash Flow Data in the financial tables on pages 5, 7 and 8 of Exhibit 1 is hereby incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of 1933.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CYREN
Ltd. (Registrant) |
||
Date: November 13, 2017 | By: | /s/ J. Michael Myshrall |
J. Michael Myshrall | ||
Chief Financial Officer |
3
Exhibit 1
PRESS RELEASE
Cyren Announces Third Quarter 2017 Financial Results
- - -
Continued traction with Cyren Cloud Security
Strategic investment by Warburg Pincus
McLean, Va. – November 13, 2017 – Cyren (NASDAQ: CYRN) today announced its third quarter 2017 financial results for the period ending September 30, 2017.
In the third quarter, Cyren continued its penetration of enterprise accounts purchasing the Cyren Cloud Security platform for email, web, and DNS security. During the quarter, Cyren signed over 60 new enterprise customers and increased its average new order size by over 250% compared to the second quarter. Cyren also renewed and expanded a number of existing large enterprise accounts.
During the third quarter, Cyren also added several Threat Intelligence Services contracts, including a multi-million dollar expansion with one of its largest customers who is using Cyren’s Phishing Intelligence solution to protect millions of users globally. The contract expansion offsets some smaller customer contracts that were not renewed over the past two quarters.
Last week Warburg Pincus, one of the world’s most successful growth-focused private equity firms, announced a $19.6 million private placement in the company, as well as its intention to acquire up to 75% of Cyren’s partially diluted outstanding shares through a tender offer.
“We are pleased with the progress we made during the third quarter to expand our Enterprise business,” said Lior Samuelson, CEO and Chairman of the Board at Cyren. “It’s great to see that the Cyren Cloud Security platform is proving its ability to scale up to larger enterprise accounts with tens of thousands of users. We were also thrilled to receive the investment by Warburg Pincus, which will help Cyren accelerate its growth plans and further establish the company as a leading provider of cloud-based cybersecurity solutions.”
Third Quarter 2017 Financial Highlights:
● | Revenues for the third quarter of 2017 were $7.6 million, compared to $7.9 million during the third quarter of 2016. |
● | GAAP net loss for the third quarter of 2017 was $3.6 million, compared to a net loss of $1.0 million in the third quarter of 2016. |
● | GAAP loss per basic and diluted share for the third quarter of 2017 was $0.09, compared to a loss of $0.02 per basic and diluted share for the third quarter of 2016. |
● | Non-GAAP net loss for the third quarter of 2017 was $3.3 million, compared to a Non-GAAP net loss of $0.8 million for the third quarter of 2016. |
● | Non-GAAP loss per basic and diluted share was $0.09 for the third quarter of 2017, compared to a Non-GAAP loss of $0.02 per share in third quarter of 2016. |
● | Operating cash usage during the third quarter was $0.3 million, compared to operating cash usage of $0.3 million in the third quarter of 2016. |
● | Net cash usage during the third quarter was $1.6 million, compared to net cash usage of $1.2 million during the third quarter of 2016. |
● | Cash balance as of September 30, 2017 was $9.9 million, compared to $11.6 million as of June 30, 2017. The company carries convertible notes with a principal balance of $6.3 million, which were issued at the end of Q1 2017. |
For information regarding the non-GAAP financial measures discussed in this release, please see “Use of Non-GAAP Financial Measures” and “Reconciliation of Selected GAAP Measures to Non-GAAP Measures.”
Recent Business Highlights:
● | In the third quarter, Cyren increased its penetration of large enterprise accounts with several notable new customers using the CCS platform, ranging from 3,000 to 30,000 seats. Cyren now services large enterprises in both North America and Europe with accounts in excess of 100,000 enterprise seats. |
● | Cyren recently released version 4.2 of its CCS platform, which adds email archiving to the portfolio of email security, web security, DNS security, and cloud sandboxing. Cyren’s archiving service delivers fast search and eDiscovery, tamper-proof storage, and provides regulatory compliance with email management, protection and retention in the cloud. |
● | On November 6, Warburg Pincus, a global private equity firm focused on growth investing, purchased approximately 10.6 million shares in a private placement at $1.85 per share, representing approximately 21.3% of Cyren’s outstanding shares, which yielded gross proceeds of approximately $19.6 million to Cyren. Warburg Pincus also announced its intention to commence a “Special Tender Offer” pursuant to Israeli law to increase its ownership in Cyren, up to a maximum of 75% of Cyren’s partially diluted outstanding shares. The complete terms and conditions of the offer, including important U.S. and Israeli income and withholding tax considerations relating to the offer, will be contained in the Offer to Purchase to be included as an exhibit to the Tender Offer Statement on Schedule TO which will be filed with the U.S. Securities and Exchange Commission (SEC) and with the Israeli Securities Authority (ISA) when the offer is commenced. |
2 |
Financial Results Conference Call:
The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Monday, November 13, 2017 to discuss third quarter results as well as the strategic investment by Warburg Pincus.
U.S. Dial-in Number: | 1-800-441-0022 |
Israel Dial-in Number: | 1-80-924-6042 |
International Dial-in Number: | 1-719-457-2603 |
The call will be simultaneously webcast live on the investor relations section of Cyren’s website at www.cyren.com/ir.html, or by using the following link: http://public.viavid.com/index.php?id=127117.
For those unable to participate in the live conference call, a replay will be available until November 27, 2017. To access the replay, the U.S. dial in number is 1-844-512-2921 and the non-U.S. dial in number is 1-412-317-6671. Callers will be prompted for replay conference ID number 5102623. An archived version of the webcast will also be available on the investor relations section of the company's website.
About Cyren:
More than 1.3 billion users around the world rely on Cyren’s 100% cloud internet security solutions to protect them against cyber attacks and data loss every day. Powered by the world’s largest security cloud, Cyren (NASDAQ and TASE: CYRN) delivers fast time to protection from cyber threats with award-winning security as a service for web, email, sandboxing, and DNS for enterprises, and embedded threat intelligence solutions for security vendors and service providers. Customers like Google, Microsoft and Check Point are just a few of the businesses that depend on Cyren every day to power their security. Learn more at www.cyren.com.
Blog: http://blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc or www.twitter.com/cyren_ir
Use of Non-GAAP Financial Measures:
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, executive termination costs, deferred taxes and deferred revenues related to acquisitions, one-time gain from sale of investment in affiliate, adjustments to earn-out obligations, capitalization of technology, accretion of discount on convertible note and change in fair value of the embedded conversion feature. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.
Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.
These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.
3 |
This press release contains forward-looking statements, including projections about the company's business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's Annual Reports on Form 20-F and reports on Form 6-K, which are available through www.sec.gov.
Important Information about the Tender Offer:
The description contained in this press release is neither an offer to purchase nor a solicitation of an offer to sell securities. The planned tender offer described in this press release has not commenced. At the time the planned tender offer is commenced, a tender offer statement on Schedule TO will be filed by Warburg Pincus with the SEC, and Cyren will file a solicitation/recommendation statement on Schedule 14D-9, with respect to the planned tender offer. The tender offer statement (including an offer to purchase, a related letter of transmittal and other tender offer documents) and the solicitation/recommendation statement will contain important information that should be read carefully before making any decision to tender securities in the planned tender offer. Those materials will be made available to Cyren’s stockholders at no expense to them. In addition, all of those materials (and all other tender offer documents filed with the SEC) will be made available at no charge on the SEC’s website at www.sec.gov.
Company Contact
Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com
Israel Investor Contact
Iris Lubitch
SmarTeam
+972.54.2528007
iris@smartteam.co.il
Media Contact
Matthew Zintel
Zintel Public Relations
+1.281.444.1590
matthew.zintel@zintelpr.com
4 |
CYREN LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except per share amounts)
Three months ended | Nine months ended | |||||||||||||||
September 30 | September 30 | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Unaudited | Unaudited | Unaudited | Unaudited | |||||||||||||
Revenues | $ | 7,561 | $ | 7,902 | $ | 23,277 | $ | 22,872 | ||||||||
Cost of revenues | 3,094 | 2,747 | 9,123 | 7,360 | ||||||||||||
Gross profit | 4,467 | 5,155 | 14,154 | 15,512 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development, net | 2,286 | 2,072 | 6,929 | 6,453 | ||||||||||||
Sales and marketing | 4,071 | 2,532 | 11,395 | 7,302 | ||||||||||||
General and administrative | 1,731 | 1,475 | 4,973 | 4,863 | ||||||||||||
Total operating expenses | 8,088 | 6,079 | 23,297 | 18,618 | ||||||||||||
Operating loss | (3,621 | ) | (924 | ) | (9,143 | ) | (3,106 | ) | ||||||||
Other income | - | (2 | ) | 451 | 5 | |||||||||||
Financial expense, net | (58 | ) | (68 | ) | (263 | ) | (201 | ) | ||||||||
Loss before taxes | (3,679 | ) | (994 | ) | (8,955 | ) | (3,302 | ) | ||||||||
Tax benefit (expense) | 51 | 19 | 148 | (7 | ) | |||||||||||
Net loss | $ | (3,628 | ) | $ | (975 | ) | $ | (8,807 | ) | $ | (3,309 | ) | ||||
Loss per share - basic | $ | (0.09 | ) | $ | (0.02 | ) | $ | (0.22 | ) | $ | (0.08 | ) | ||||
Loss per share - diluted | $ | (0.09 | ) | $ | (0.02 | ) | $ | (0.22 | ) | $ | (0.08 | ) | ||||
Weighted average number of shares outstanding: | ||||||||||||||||
Basic | 39,229 | 39,132 | 39,205 | 39,125 | ||||||||||||
Diluted | 39,229 | 39,132 | 39,205 | 39,125 |
5 |
CYREN LTD.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in thousands of U.S.dollars, except per share amounts)
Three months ended | Nine months ended | |||||||||||||||
September 30 | September 30 | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Unaudited | Unaudited | Unaudited | Unaudited | |||||||||||||
GAAP operating loss | $ | (3,621 | ) | $ | (924 | ) | $ | (9,143 | ) | $ | (3,106 | ) | ||||
Stock-based compensation (1) | 248 | 250 | 809 | 747 | ||||||||||||
Amortization of intangible assets (2) | 1,135 | 797 | 3,292 | 2,046 | ||||||||||||
Executive terminations (5) | - | 30 | - | 87 | ||||||||||||
Adjustment to deferred revenues (6) | - | - | - | 66 | ||||||||||||
Capitalization of technology (8) | (995 | ) | (839 | ) | (2,716 | ) | (2,245 | ) | ||||||||
Non-GAAP operating loss | $ | (3,233 | ) | $ | (686 | ) | $ | (7,758 | ) | $ | (2,405 | ) | ||||
GAAP net loss | $ | (3,628 | ) | $ | (975 | ) | $ | (8,807 | ) | $ | (3,309 | ) | ||||
Stock-based compensation (1) | 248 | 250 | 809 | 747 | ||||||||||||
Amortization of intangible assets (2) | 1,135 | 797 | 3,292 | 2,046 | ||||||||||||
Adjustment to earn-out liabilities and related expenses (3) | 27 | - | 91 | - | ||||||||||||
Amortization of deferred tax assets (4) | (65 | ) | (66 | ) | (186 | ) | (216 | ) | ||||||||
Executive terminations (5) | - | 30 | - | 87 | ||||||||||||
Adjustment to deferred revenues (6) | - | - | - | 66 | ||||||||||||
Gain from sale of investment in affiliate (7) | - | - | (450 | ) | - | |||||||||||
Capitalization of technology (8) | (1,026 | ) | (839 | ) | (2,765 | ) | (2,276 | ) | ||||||||
Accretion of discount on convertible note (9) | 159 | - | 330 | - | ||||||||||||
Change in fair value of embedded conversion feature on convertible note (10) | (198 | ) | - | (465 | ) | - | ||||||||||
Non-GAAP net loss | $ | (3,348 | ) | $ | (803 | ) | $ | (8,151 | ) | $ | (2,855 | ) | ||||
GAAP loss per share (diluted) | $ | (0.09 | ) | $ | (0.02 | ) | $ | (0.22 | ) | $ | (0.08 | ) | ||||
Stock-based compensation (1) | 0.01 | 0.00 | 0.02 | 0.02 | ||||||||||||
Amortization of intangible assets (2) | 0.03 | 0.02 | 0.09 | 0.05 | ||||||||||||
Adjustment to earn-out liabilities and related expenses (3) | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Amortization of deferred tax assets (4) | (0.00 | ) | (0.00 | ) | (0.00 | ) | 0.00 | |||||||||
Executive terminations (5) | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Adjustment to deferred revenues (6) | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Gain from sale of investment in affiliate (7) | 0.00 | 0.00 | (0.01 | ) | 0.00 | |||||||||||
Capitalization of technology (8) | (0.03 | ) | (0.02 | ) | (0.08 | ) | (0.06 | ) | ||||||||
Accretion of discount on convertible note (9) | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Change in fair value of embedded conversion feature on convertible note (10) | (0.01 | ) | 0.00 | (0.01 | ) | 0.00 | ||||||||||
Non-GAAP loss per share (diluted) | $ | (0.09 | ) | $ | (0.02 | ) | $ | (0.21 | ) | $ | (0.07 | ) | ||||
Numbers of shares used in computing non-GAAP loss per share (diluted) | 39,229 | 39,132 | 39,205 | 39,125 | ||||||||||||
(1) Stock-based compensation | ||||||||||||||||
Cost of revenues | $ | 17 | $ | 24 | $ | 76 | $ | 51 | ||||||||
Research and development | 61 | 77 | 228 | 243 | ||||||||||||
Sales and marketing | 67 | 47 | 180 | 153 | ||||||||||||
General and administrative | 103 | 102 | 325 | 300 | ||||||||||||
$ | 248 | $ | 250 | $ | 809 | $ | 747 | |||||||||
(2) Amortization of intangible assets | 962 | 609 | 2,785 | 1,480 | ||||||||||||
Cost of revenues | $ | 173 | $ | 188 | $ | 507 | $ | 566 | ||||||||
Sales and marketing | - | 0 | - | 0 | ||||||||||||
$ | 1,135 | $ | 797 | $ | 3,292 | $ | 2,046 | |||||||||
(3) Adjustment to earn-out liabilities and related expenses | ||||||||||||||||
Financial expenses, net | $ | 27 | $ | - | $ | 91 | $ | - | ||||||||
(4) Amortization of deferred tax assets | ||||||||||||||||
Tax benefit (expense) | $ | (65 | ) | $ | (66 | ) | $ | (186 | ) | $ | (216 | ) | ||||
(5) Executive terminations | ||||||||||||||||
Sales and marketing | $ | - | $ | 30 | $ | - | $ | 87 | ||||||||
(6) Adjustment to deferred revenues | ||||||||||||||||
Revenues | $ | - | $ | - | $ | - | $ | 66 | ||||||||
(7) Gain from sale of investment in affiliate | ||||||||||||||||
Other Income | $ | - | $ | - | $ | (450 | ) | $ | - | |||||||
(8) Capitalization of technology | ||||||||||||||||
Research and development | $ | (995 | ) | $ | (839 | ) | $ | (2,716 | ) | $ | (2,245 | ) | ||||
Financial expenses, net | (31 | ) | - | (49 | ) | (31 | ) | |||||||||
$ | (1,026 | ) | $ | (459 | ) | $ | (2,765 | ) | $ | (2,276 | ) | |||||
(9) Accretion of discount on convertible note | ||||||||||||||||
Financial expenses, net | $ | 159 | $ | - | $ | 330 | $ | - | ||||||||
(10) Change in fair value of embedded conversion feature on convertible note | ||||||||||||||||
Financial expenses, net | $ | (198 | ) | $ | - | $ | (465 | ) | $ | - |
6 |
CYREN LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars)
September 30 | December 31 | |||||||
2017 | 2016 | |||||||
Unaudited | Audited | |||||||
Assets | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 9,919 | $ | 10,621 | ||||
Trade receivables, net | 2,576 | 3,061 | ||||||
Prepaid expenses and other receivables | 1,607 | 918 | ||||||
Total current assets | 14,102 | 14,600 | ||||||
Property and equipment, net | 2,861 | 2,081 | ||||||
Goodwill and intangible assets, net | 31,251 | 29,867 | ||||||
Severance pay fund | 616 | 604 | ||||||
Lease deposits | 498 | 380 | ||||||
Total long-term assets | 35,226 | 32,932 | ||||||
Total assets | $ | 49,328 | $ | 47,532 | ||||
Liabilities and Shareholders’ Equity | ||||||||
Current Liabilities: | ||||||||
Trade payables | $ | 1,658 | $ | 764 | ||||
Employees and payroll accruals | 2,857 | 2,528 | ||||||
Accrued expenses and other liabilities | 878 | 755 | ||||||
Earn-out consideration | 3,503 | 3,041 | ||||||
Deferred revenues | 5,767 | 4,609 | ||||||
Total current liabilities | 14,663 | 11,697 | ||||||
Long term Convertible Note | 4,617 | - | ||||||
Embedded conversion feature on Convertible Note | 1,549 | - | ||||||
Deferred revenues | 874 | 1,788 | ||||||
Deferred tax liability | 1,367 | 1,374 | ||||||
Accrued severance pay | 894 | 816 | ||||||
Other liabilities | 133 | 119 | ||||||
Total long-term liabilities | 9,434 | 4,097 | ||||||
Shareholders’ equity | 25,231 | 31,738 | ||||||
Total liabilities and shareholders’ equity | $ | 49,328 | $ | 47,532 |
7 |
CYREN LTD.
CONDENSED CONSOLIDATED CASH FLOW DATA
(in thousands of U.S. dollars)
Three months ended | Nine months ended | |||||||||||||||
September 30 | September 30 | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Unaudited | Unaudited | Unaudited | Unaudited | |||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net loss | $ | (3,628 | ) | $ | (975 | ) | $ | (8,807 | ) | $ | (3,309 | ) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||||||
Loss on disposal of property and equipment | - | 1 | 1 | 3 | ||||||||||||
Depreciation | 311 | 320 | 866 | 643 | ||||||||||||
Stock-based compensation | 248 | 250 | 809 | 497 | ||||||||||||
Amortization of intangible assets | 1,135 | 855 | 3,292 | 1,249 | ||||||||||||
Accrued interest and accretion of discount on credit line | - | - | - | (19 | ) | |||||||||||
Accretion of discount on convertible note | 159 | - | 330 | - | ||||||||||||
Change in fair value of embedded conversion feature on convertible note | (198 | ) | - | (465 | ) | - | ||||||||||
Other income related to investment in affiliate | - | - | (450 | ) | - | |||||||||||
Other expenses related to the earn-out consideration | 27 | - | 91 | - | ||||||||||||
Deferred taxes | (51 | ) | (47 | ) | (146 | ) | (120 | ) | ||||||||
Changes in assets and liabilities: | ||||||||||||||||
Trade receivables | 757 | (31 | ) | 368 | 98 | |||||||||||
Prepaid expenses and other receivables | 203 | (171 | ) | (646 | ) | (363 | ) | |||||||||
Change in long-term lease deposits | (85 | ) | (214 | ) | (112 | ) | (228 | ) | ||||||||
Trade payables | 72 | 155 | 81 | (54 | ) | |||||||||||
Employees and payroll accruals, accrued expenses and other liabilities | (28 | ) | 154 | 457 | 114 | |||||||||||
Deferred revenues | 790 | (580 | ) | 244 | 3,247 | |||||||||||
Accrued severance pay, net | 13 | (18 | ) | 66 | 42 | |||||||||||
Other long-term liabilities | - | (2 | ) | - | (3 | ) | ||||||||||
Net cash used in operating activities | (275 | ) | (303 | ) | (4,021 | ) | 1,797 | |||||||||
Cash flows from investing activities: | ||||||||||||||||
Proceeds from sale of investment in affiiate | - | - | 450 | - | ||||||||||||
Capitalization of technology, net of grants received | (1,026 | ) | (459 | ) | (2,765 | ) | (1,437 | ) | ||||||||
Purchase of property and equipment | (345 | ) | (386 | ) | (818 | ) | (649 | ) | ||||||||
Net cash used in investing activities | (1,371 | ) | (845 | ) | (3,133 | ) | (2,086 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||||||
Proceeds from convertible note | - | - | 6,300 | - | ||||||||||||
Payment of credit line | - | - | - | (4,150 | ) | |||||||||||
Proceeds from options exercised | 8 | - | 75 | - | ||||||||||||
Net cash provided by (used in) financing activities | 8 | - | 6,375 | (4,150 | ) | |||||||||||
Effect of exchange rate changes on cash | (11 | ) | (46 | ) | 77 | 53 | ||||||||||
Decrease in cash and cash equivalents | (1,649 | ) | (1,194 | ) | (702 | ) | (4,386 | ) | ||||||||
Cash and cash equivalents at the beginning of the period | 11,568 | 14,026 | 10,621 | 16,379 | ||||||||||||
Cash and cash equivalents at the end of the period | $ | 9,919 | $ | 12,832 | $ | 9,919 | $ | 11,993 |
8